Cargando…
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
• 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated.
Autores principales: | Skwara, Amanda J., Schilder, Russell J., Zibelli, Allison, Rosenblum, Norman G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862313/ https://www.ncbi.nlm.nih.gov/pubmed/24371706 http://dx.doi.org/10.1016/j.gynor.2013.06.005 |
Ejemplares similares
-
Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
por: Eldredge-Hindy, Harriet Belding, et al.
Publicado: (2014) -
Vaginal cuff dehiscence with bowel evisceration after robotic hysterectomy
por: Akdemir, Ali, et al.
Publicado: (2014) -
Small Bowel Evisceration after Spontaneous Vaginal Cuff Rupture
por: McMaster, Brian C, et al.
Publicado: (2019) -
Simulation-based Training Curriculum for the Management of Vaginal Cuff Dehiscence and Evisceration
por: Chapman, Amelia D, et al.
Publicado: (2020) -
Transvaginal Management of Vaginal Cuff Dehiscence with Bowel Evisceration following Delayed Diagnosis
por: Bleull, Samantha, et al.
Publicado: (2017)